What are Clinical Trials?
New tests and treatments aren’t offered to the public as soon as they’re made. They need to be studied. Clinical trials study how safe and helpful tests and treatments are. When found to be safe and helpful, they may become tomorrow’s standard of care. Clinical trials can study many things, such as:
- New drugs not yet approved by the U.S. FDA (Food and Drug Administration)
- New uses of drugs already approved by the FDA
- New ways to give drugs, such as in pill form
- Use of alternative medicines, such as herbs and vitamins
- New tests to find and track disease
- Drugs or procedures that relieve symptoms
ClinicalTrials.gov
ClinicalTrials.gov is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.
Genomic Focus helps you find personalized options to fight cancer – for free.
Cholangiocarcinoma Clinical Trials
Please note, the following clinical trials are not the only clinical trials available for cholangiocarcinoma patients, the following clinical trials were submitted by the organizations conducting the trial. Please visit clinicaltrials.gov for a more comprehensive list.
It is not the intention of the Cholangiocarcinoma Foundation to provide specific medical advice. We provide website users with information to help them better understand their health conditions and the current approaches related to prevention, diagnosis, treatment and supportive care. You are urged to always seek the advice of your physician or other qualified healthcare provider.
Learn More About Clinical Trials
Clinical Trials
Trial Phases
Informed Consent
Randomized Control Trials
Placebos
Standard of Care
Biopsies
Basket Trials
Understanding your Clinical Trial Result
“The most powerful and positive force in medicine, is that of a self-advocating patient!”
Our Chief Patient Officer, Melinda Bachini uses that statement as a signature on every email she sends. As a 15-year survivor of Cholangiocarcinoma, Melinda knows from first-hand experience, with patient education comes knowledge, understanding, and hope.
We are excited to share the newly released video, Understanding Your Clinical Trials Results. Produced in partnership with Incyte, Cholangiocarcinoma Foundation and Target Cancer Foundation, the video is an invaluable resource to help patients understand their clinical trial results.
Researchers from Fred Hutchinson Cancer Center, the American Cancer Society Cancer Action Network, and peer institutions released new findings in the Journal of Clinical Oncology showing that when all types of cancer research studies are considered, at least one in five people with cancer, or 21.9%, participate in some form of clinical research.
The study evaluated all categories of cancer studies, such as treatment trials, biorepository studies, and quality of life studies—the first time an estimate of participation in all types of cancer studies has been reported. Moreover, enrollment in cancer treatment trials was 7.1%, a notably higher participation rate than previous estimates of 2%- 3%.
The study also found that enrollment in treatment trials was over five-fold higher at National Cancer Institute-designated cancer centers than at community sites (21.6% versus 4.1%), reflecting the impact that NCI funding for staff and infrastructure has on an institution’s ability to offer trials and recruit patients.